EmpressTx

Empress Therapeutics is a biotechnology company based in Cambridge, Massachusetts. Founded in 2020 by Flagship Pioneering, the company is a relatively small organization with 31 employees. Empress Therapeutics focuses on developing oral medications for a wide range of diseases. Their approach leverages a proprietary platform called Empress Chemilogics(TM) which utilizes insights from DNA and the human body's chemistry to design and create innovative drug candidates. What sets Empress Therapeutics apart is their unique Chemilogics(TM) platform. This platform enables them to generate potential medicines rapidly, predictably, and efficiently, aiming to bring first- or best-in-class oral medications to patients more quickly than traditional drug development methods. For more information about Empress Therapeutics and their groundbreaking work, visit their website at empresstx.com.